Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Navigating the Flood of 2025-2026 Clinical Trial Data

    August 24, 2026

    Navigating Rapid Advances in Medical Research: What Clinical Researchers Need to Know

    August 23, 2026

    Overcoming Access Barriers to Evidence-Based Psychiatric Treatments

    August 22, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Health Magazine
    • Home
    • Environmental Health
    • Health Technology
    • Medical Research
    • Mental Health
    • Nutrition Science
    • Pharma
    • Public Health
    • Discover
      • Daily Health Tips
      • Financial Health & Stability
      • Holistic Health & Wellness
      • Mental Health
      • Nutrition & Dietary Trends
      • Professional & Personal Growth
    • Our Mission
    Health Magazine
    Home » News » Study provides insight into how long-term inflammation contributes to cognitive decline
    Discover

    Study provides insight into how long-term inflammation contributes to cognitive decline

    healthadminBy healthadminJuly 7, 2026No Comments3 Mins Read
    Study provides insight into how long-term inflammation contributes to cognitive decline
    Share
    Facebook Twitter Reddit Telegram Pinterest Email



    King’s College London Research, nature communicationsprovides insight into how long-term inflammation contributes to cognitive decline in diseases such as Alzheimer’s disease, aging, depression, and the lingering neurological effects of viral infections.

    Scientists have discovered that adding molecules involved in inflammatory responses to stem cells in the hippocampus impedes the development of new neurons. The formation of new neurons in this region, known as hippocampal neurogenesis, is essential for learning, memory, and regulating mood. It is one of the few parts of the human brain where new neurons are created in adulthood. Changes in adult hippocampal neurogenesis are associated with aging, neurodegeneration, and mood disorders such as depression.

    The study focused on cytokines, which are chemical signals released by the body in response to threats such as viral infections. Cytokines ultimately act as triggers for the rest of the immune response, helping the body fight infections. High cytokine levels are also a hallmark of chronic inflammation.

    Viral infections have previously been associated with changes in the ability of parts of the hippocampus to generate new neurons. However, until now it was unknown how infection and inflammatory cytokines affect the generation of new neurons.

    When researchers added a specific cytokine called TNF-α to human hippocampal stem cells, the stem cells were prevented from developing into neurons. Instead, they switched to a state of “immune alarm” and released signals that attracted important immune cells known as T cells, which caused inflammation and reduced the production of new nerve cells.

    “What surprised us most was that the stem cells were not just compromised by inflammation, but that they actively adopted behaviors that could potentially sustain an immune response in the brain,” said lead author Dr. Ting A.D. Nissen, who completed the study as part of his PhD at King’s College London.

    Our findings reveal a new link between chronic inflammation and a reduced ability of the brain to generate new neurons.

    Inflammatory signals can effectively redirect hippocampal stem cells away from their normal role of generating neurons and instead towards supporting immune activity. ”

    Professor Sandrine Thuret, co-corresponding author, Professor of Neuroscience, King’s College London

    The researchers also identified an unexpected signaling pathway behind this effect that involves type I interferon, a molecule normally associated with the body’s antiviral defenses. Blocking interferon signaling with existing therapeutic antibodies reversed some of the effects of inflammation by restoring the production of new neurons and preventing the recruitment of T cells involved in the immune response.

    Co-author Professor Linda S. Kravinskis, Professor of Viral Immunology at King’s College London, added: “Our study reveals a new mechanism that may help explain why ongoing inflammation has such a negative impact on brain health. Importantly, it also points to possible treatments to protect or restore the brain’s ability to regenerate.”

    This research is a collaboration between the Department of Infectious Diseases, School of Life Sciences and Medicine, and the Department of Basic and Clinical Neurosciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London.

    This research was funded by the Wellcome Trust as part of the ‘Neuroimmune Interactions in Health and Disease Wellcome Trust PhD Programme’ and received funding from the UK Medical Research Council, the Medical Research Council Discovery Award, a PhD studentship awarded by the UK Medical Research Council, the Galen and Hilary Weston Foundation, the National Institute for Health Research (NIHR) Biomedical Research Center based at Guy’s and St Thomas NHS Foundation Trust, and King’s College London.

    sauce:

    Reference magazines:

    Nissen, TAD, Others. (2026) TNF-α induces type I IFN signaling to suppress neurogenesis and recruit T cells. nature communications. DOI: 10.1038/s41467-026-74104-x. https://www.nature.com/articles/s41467-026-74104-x



    Source link

    Visited 7 times, 1 visit(s) today
    Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
    Previous ArticleBelgium has forever had the worst chemical record in Europe: are they violating the human rights of its citizens?
    Next Article The textbooks were wrong: Scientists reveal how human hair actually grows
    healthadmin

    Related Posts

    Texas A&M researchers build AI tool for tuberculosis drug discovery

    July 30, 2026

    New ultrasound technology breaks blood-brain barrier to treat gliomas

    July 30, 2026

    Omalizumab wins multi-allergen oral immunotherapy in multi-food allergy trial

    July 30, 2026

    MAGFLO™ NGS beads: cost-effective nucleic acid purification

    July 30, 2026

    Qureight completes $20 million Series B funding

    July 30, 2026

    Cigarette smoke extract stimulates airway cells and increases nanoplastic damage

    July 30, 2026
    Add A Comment

    Comments are closed.

    Categories

    • Daily Health Tips
    • Discover
    • Environmental Health
    • Exercise & Fitness
    • Featured
    • Featured Videos
    • Financial Health & Stability
    • Fitness
    • Fitness Updates
    • Health
    • Health Technology
    • Healthy Aging
    • Healthy Living
    • Holistic Healing
    • Holistic Health & Wellness
    • Medical Research
    • Medical Research & Insights
    • Mental Health
    • Mental Wellness
    • Natural Remedies
    • New Workouts
    • Nutrition
    • Nutrition & Dietary Trends
    • Nutrition & Superfoods
    • Nutrition Science
    • Pharma
    • Preventive Healthcare
    • Professional & Personal Growth
    • Public Health
    • Public Health & Awareness
    • Selected
    • Sleep & Recovery
    • Top Programs
    • Weight Management
    • Workouts
    Popular Posts
    • 1773313737_bacteria_-_Sebastian_Kaulitzki_46826fb7971649bfaca04a9b4cef3309-620x480.jpgHow Sino Biological ProPure™ redefines ultra-low… March 12, 2026
    • pexels-david-bartus-442116The food industry needs to act now to cut greenhouse… January 2, 2022
    • 1773729862_TagImage-3347-458389964760995353448-620x480.jpgDespite safety concerns, parents underestimate the… March 17, 2026
    • 1774403998_image_28620e4b6b0047f7ab9154b41d739db1-620x480.jpgGait pattern helps distinguish between Lewy body… March 24, 2026
    • 1773209206_futuristic_techno_design_on_background_of_supercomputer_data_center_-_Image_-_Timofeev_Vladimir_M1_4.jpegMulti-agent AI systems outperform single models… March 11, 2026
    • Leukemia-620x480.jpgBiomimetic platform powers CAR T therapy for… March 9, 2026

    Demo
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Navigating the Flood of 2025-2026 Clinical Trial Data

    By healthadminAugust 24, 2026

    A comprehensive overview of key clinical trials in 2025-2026, focusing on oncology, gene therapy, and vaccines for clinical researchers and practitioners.

    Navigating Rapid Advances in Medical Research: What Clinical Researchers Need to Know

    August 23, 2026

    Overcoming Access Barriers to Evidence-Based Psychiatric Treatments

    August 22, 2026

    Overcoming Volatility and Funding Risks in Modern Clinical Research

    August 21, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    HealthxMagazine
    HealthxMagazine

    At HealthX Magazine, we are dedicated to empowering entrepreneurs, doctors, chiropractors, healthcare professionals, personal trainers, executives, thought leaders, and anyone striving for optimal health.

    Our Picks

    Overcoming Volatility and Funding Risks in Modern Clinical Research

    August 21, 2026

    Why Traditional Clinical Trial Methods Are Failing Researchers in 2026

    August 20, 2026

    Confronting Population Health Trends and the Threat of Reversed Gains

    August 19, 2026
    New Comments
      Facebook X (Twitter) Instagram Pinterest
      • Home
      • Privacy Policy
      • Our Mission
      © 2026 ThemeSphere. Designed by ThemeSphere.

      Type above and press Enter to search. Press Esc to cancel.